Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogler, Sabine, Zimmermann, Nina, Babar, Zaheer-Ud-Din, Busse, Reinhard, Espin, Jaime, Mantel-Teeuwisse, Aukje K., Panteli, Dimitra, Suleman, Fatima, Wirtz, Veronika J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829652/
https://www.ncbi.nlm.nih.gov/pubmed/33494798
http://dx.doi.org/10.1186/s40545-021-00300-3
_version_ 1783641220514316288
author Vogler, Sabine
Zimmermann, Nina
Babar, Zaheer-Ud-Din
Busse, Reinhard
Espin, Jaime
Mantel-Teeuwisse, Aukje K.
Panteli, Dimitra
Suleman, Fatima
Wirtz, Veronika J.
author_facet Vogler, Sabine
Zimmermann, Nina
Babar, Zaheer-Ud-Din
Busse, Reinhard
Espin, Jaime
Mantel-Teeuwisse, Aukje K.
Panteli, Dimitra
Suleman, Fatima
Wirtz, Veronika J.
author_sort Vogler, Sabine
collection PubMed
description The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.
format Online
Article
Text
id pubmed-7829652
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78296522021-01-25 Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference Vogler, Sabine Zimmermann, Nina Babar, Zaheer-Ud-Din Busse, Reinhard Espin, Jaime Mantel-Teeuwisse, Aukje K. Panteli, Dimitra Suleman, Fatima Wirtz, Veronika J. J Pharm Policy Pract Commentary The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future. BioMed Central 2021-01-25 /pmc/articles/PMC7829652/ /pubmed/33494798 http://dx.doi.org/10.1186/s40545-021-00300-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Vogler, Sabine
Zimmermann, Nina
Babar, Zaheer-Ud-Din
Busse, Reinhard
Espin, Jaime
Mantel-Teeuwisse, Aukje K.
Panteli, Dimitra
Suleman, Fatima
Wirtz, Veronika J.
Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
title Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
title_full Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
title_fullStr Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
title_full_unstemmed Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
title_short Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
title_sort addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th ppri conference
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829652/
https://www.ncbi.nlm.nih.gov/pubmed/33494798
http://dx.doi.org/10.1186/s40545-021-00300-3
work_keys_str_mv AT voglersabine addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT zimmermannnina addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT babarzaheeruddin addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT bussereinhard addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT espinjaime addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT mantelteeuwisseaukjek addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT pantelidimitra addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT sulemanfatima addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference
AT wirtzveronikaj addressingthemedicinesaccesschallengethroughbalanceevidencecollaborationandtransparencykeytakeawaylessonsofthe4thppriconference

Ejemplares similares